Skip to main content

Carotid Artery Diseases

0
Pipeline Programs
6
Companies
5
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

InspireMD
InspireMDIsrael - Tel Aviv
2 programs
CGuard Prime 80cm stent systemN/A1 trial
Intravascular UtrasoundN/A1 trial
Active Trials
NCT06653387Recruiting50Est. Nov 2027
NCT04234854Unknown200Est. Mar 2023
Robocath
RobocathFrance - Rouen
1 program
Carotid Artery StentingN/A1 trial
Active Trials
NCT05093127Completed7Est. Nov 2022
Dong-A ST
Dong-A STKorea - Seoul
1 program
Intervention 1N/A1 trial
Active Trials
NCT06276374Recruiting1,556Est. Dec 2030
Boston Scientific
Boston ScientificCA - Valencia
1 program
WALLSTENT® Endoprosthesis™N/A1 trial
Active Trials
NCT00316108Completed747Est. Nov 2007

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
InspireMDCGuard Prime 80cm stent system
Dong-A STIntervention 1
RobocathCarotid Artery Stenting
InspireMDIntravascular Utrasound
Boston ScientificWALLSTENT® Endoprosthesis™

Clinical Trials (5)

Total enrollment: 2,560 patients across 5 trials

NCT06653387InspireMDCGuard Prime 80cm stent system

A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach

Start: Nov 2024Est. completion: Nov 202750 patients
N/ARecruiting
NCT06276374Dong-A STIntervention 1

Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients

Start: Jul 2024Est. completion: Dec 20301,556 patients
N/ARecruiting
NCT05093127RobocathCarotid Artery Stenting

CArotid Robotic Procedure Evaluation

Start: Nov 2021Est. completion: Nov 20227 patients
N/ACompleted
NCT04234854InspireMDIntravascular Utrasound

OPTIMAl Endovascular Exclusion of Consecutive Patient High-risk Carotid Plaque Using the MicroNet Covered Stent

Start: Jan 2020Est. completion: Mar 2023200 patients
N/AUnknown
NCT00316108Boston ScientificWALLSTENT® Endoprosthesis™

Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH)

Start: Feb 2002Est. completion: Nov 2007747 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 2,560 patients
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.